Carolyn S Calfee1, David R Janz2, Gordon R Bernard2, Addison K May2, Kirsten N Kangelaris3, Michael A Matthay4, Lorraine B Ware2. 1. Division of Pulmonary and Critical Care Medicine, Departments of Medicine and Anesthesia, University of California San Francisco, San Francisco, CA; Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA. Electronic address: carolyn.calfee@ucsf.edu. 2. Division of Allergy, Pulmonary and Critical Care, Department of Medicine, Vanderbilt University, Nashville, TN. 3. Division of Hospital Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA. 4. Division of Hospital Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA; Division of Pulmonary and Critical Care Medicine, Departments of Medicine and Anesthesia, University of California San Francisco, San Francisco, CA.
Abstract
BACKGROUND: ARDS is a heterogeneous syndrome that encompasses lung injury from both direct and indirect sources. Direct ARDS (pneumonia, aspiration) has been hypothesized to cause more severe lung epithelial injury than indirect ARDS (eg, nonpulmonary sepsis); however, this hypothesis has not been well studied in humans. METHODS: We measured plasma biomarkers of lung epithelial and endothelial injury and inflammation in a single-center study of 100 patients with ARDS and severe sepsis and in a secondary analysis of 853 patients with ARDS drawn from a multicenter randomized controlled trial. Biomarker levels in patients with direct vs indirect ARDS were compared in both cohorts. RESULTS: In both studies, patients with direct ARDS had significantly higher levels of a biomarker of lung epithelial injury (surfactant protein D) and significantly lower levels of a biomarker of endothelial injury (angiopoietin-2) than those with indirect ARDS. These associations were robust to adjustment for severity of illness and ARDS severity. In the multicenter study, patients with direct ARDS also had lower levels of von Willebrand factor antigen and IL-6 and IL-8, markers of endothelial injury and inflammation, respectively. The prognostic value of the biomarkers was similar in direct and indirect ARDS. CONCLUSIONS: Direct lung injury in humans is characterized by a molecular phenotype consistent with more severe lung epithelial injury and less severe endothelial injury. The opposite pattern was identified in indirect lung injury. Clinical trials of novel therapies targeted specifically at the lung epithelium or endothelium may benefit from preferentially enrolling patients with direct and indirect ARDS, respectively.
RCT Entities:
BACKGROUND: ARDS is a heterogeneous syndrome that encompasses lung injury from both direct and indirect sources. Direct ARDS (pneumonia, aspiration) has been hypothesized to cause more severe lung epithelial injury than indirect ARDS (eg, nonpulmonary sepsis); however, this hypothesis has not been well studied in humans. METHODS: We measured plasma biomarkers of lung epithelial and endothelial injury and inflammation in a single-center study of 100 patients with ARDS and severe sepsis and in a secondary analysis of 853 patients with ARDS drawn from a multicenter randomized controlled trial. Biomarker levels in patients with direct vs indirect ARDS were compared in both cohorts. RESULTS: In both studies, patients with direct ARDS had significantly higher levels of a biomarker of lung epithelial injury (surfactant protein D) and significantly lower levels of a biomarker of endothelial injury (angiopoietin-2) than those with indirect ARDS. These associations were robust to adjustment for severity of illness and ARDS severity. In the multicenter study, patients with direct ARDS also had lower levels of von Willebrand factor antigen and IL-6 and IL-8, markers of endothelial injury and inflammation, respectively. The prognostic value of the biomarkers was similar in direct and indirect ARDS. CONCLUSIONS: Direct lung injury in humans is characterized by a molecular phenotype consistent with more severe lung epithelial injury and less severe endothelial injury. The opposite pattern was identified in indirect lung injury. Clinical trials of novel therapies targeted specifically at the lung epithelium or endothelium may benefit from preferentially enrolling patients with direct and indirect ARDS, respectively.
Authors: P Pelosi; D D'Onofrio; D Chiumello; S Paolo; G Chiara; V L Capelozzi; C S V Barbas; M Chiaranda; L Gattinoni Journal: Eur Respir J Suppl Date: 2003-08
Authors: Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay Journal: Crit Care Med Date: 2003-04 Impact factor: 7.598
Authors: Eric P Schmidt; Guoyun Li; Lingyun Li; Li Fu; Yimu Yang; Katherine H Overdier; Ivor S Douglas; Robert J Linhardt Journal: J Biol Chem Date: 2014-02-07 Impact factor: 5.157
Authors: Martin Depner; Oliver Fuchs; Jon Genuneit; Anne M Karvonen; Anne Hyvärinen; Vincent Kaulek; Caroline Roduit; Juliane Weber; Bianca Schaub; Roger Lauener; Michael Kabesch; Petra Ina Pfefferle; Urs Frey; Juha Pekkanen; Jean-Charles Dalphin; Josef Riedler; Charlotte Braun-Fahrländer; Erika von Mutius; Markus J Ege Journal: Am J Respir Crit Care Med Date: 2014-01-15 Impact factor: 21.405
Authors: Lorraine B Ware; Mark D Eisner; B Taylor Thompson; Polly E Parsons; Michael A Matthay Journal: Am J Respir Crit Care Med Date: 2004-06-16 Impact factor: 21.405
Authors: V Marco Ranieri; Gordon D Rubenfeld; B Taylor Thompson; Niall D Ferguson; Ellen Caldwell; Eddy Fan; Luigi Camporota; Arthur S Slutsky Journal: JAMA Date: 2012-06-20 Impact factor: 56.272
Authors: Lorraine B Ware; Tatsuki Koyama; Zhiguo Zhao; David R Janz; Nancy Wickersham; Gordon R Bernard; Addison K May; Carolyn S Calfee; Michael A Matthay Journal: Crit Care Date: 2013-10-24 Impact factor: 9.097
Authors: W B LaRivière; S Liao; S A McMurtry; K Oshima; X Han; F Zhang; S Yan; S M Haeger; M Ransom; J A Bastarache; R J Linhardt; E P Schmidt; Y Yang Journal: Am J Physiol Lung Cell Mol Physiol Date: 2020-04-22 Impact factor: 5.464
Authors: Nadir Yehya; Neal J Thomas; Nuala J Meyer; Jason D Christie; Robert A Berg; Susan S Margulies Journal: Intensive Care Med Date: 2016-04-21 Impact factor: 17.440
Authors: John P Reilly; Nuala J Meyer; Michael Gs Shashaty; Brian J Anderson; Caroline Ittner; Thomas G Dunn; Brian Lim; Caitlin Forker; Michael P Bonk; Ethan Kotloff; Rui Feng; Edward Cantu; Nilam S Mangalmurti; Carolyn S Calfee; Michael A Matthay; Carmen Mikacenic; Keith R Walley; James Russell; David C Christiani; Mark M Wurfel; Paul N Lanken; Muredach P Reilly; Jason D Christie Journal: J Clin Invest Date: 2021-01-04 Impact factor: 14.808